Neil Graham
Direttore/Membro del Consiglio presso ASLAN PHARMACEUTICALS LIMITED
Patrimonio netto: - $ in data 31/05/2024
Profilo
Neil Graham is currently an Independent Director at ASLAN Pharmaceuticals Pte Ltd., Allakos, Inc., Aslan Pharmaceuticals Ltd., and Zura Bio Ltd.
He previously worked as a Director-HIV Medical Affairs at Glaxo Wellcome Plc, an Independent Non-Executive Director at Syntara Ltd., and the VP-Strategic Program Direction & Immunology at Regeneron Pharmaceuticals, Inc. He also held positions as the SVP-Program & Portfolio Management at Trimeris, Inc., the Chief Medical Officer & VP-Clinical Development at XTL Biopharmaceuticals Ltd., and the Senior Vice President-Program & Portfolio at Vertex, Inc. Additionally, he was an Associate Professor at Johns Hopkins Bloomberg School of Public Health.
Dr. Graham obtained a doctorate degree from the University of Adelaide.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Neil Graham
| Società | Posizione | Inizio |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 18/02/2021 |
| ZURA BIO LIMITED | Direttore/Membro del Consiglio | 01/03/2023 |
| ALLAKOS INC. | Direttore/Membro del Consiglio | 30/08/2023 |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Neil Graham
| Società | Posizione | Fine |
|---|---|---|
| SYNTARA LIMITED | Direttore/Membro del Consiglio | 03/10/2023 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | 18/07/2022 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2020 |
| VERTEX, INC. | Corporate Officer/Principal | 01/11/2009 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01/02/2007 |
Formazione di Neil Graham
| University of Adelaide | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 8 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| SYNTARA LIMITED | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| VERTEX, INC. | Technology Services |
| ASLAN PHARMACEUTICALS LIMITED | Health Technology |
| ZURA BIO LIMITED | Health Technology |
| ALLAKOS INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
- Borsa valori
- Insiders
- Neil Graham
